AS
SPTBDJ
JE
JD
MF
EGPersonalised emails written for every contact · 97% deliverability · live in 60 seconds
| Company | What they do | Location | Size | Hiring |
|---|---|---|---|---|
Anavex Life Sciencesanavex.com ASSPTB |
Anavex Life Sciences Corp. (Nasdaq: AVXL) is a publicly traded biopharmaceutical company developing novel therapeutics for neurode | New York City, New York | 11-50 | — |
Acadia Pharmaceuticalsacadia.com FLNS  LC |
Acadia Pharmaceuticals is a publicly traded biopharmaceutical company developing and commercializing treatments for underserved ne | San Diego, California | 1001-5000 | — |
Oligomerixoligomerix.com JPBCED |
Oligomerix is a privately held clinical-stage biotechnology company developing oral small molecule therapeutics that inhibit tau s | Bronx, New York | 11-50 | — |
Initial Therapeuticsinitialtx.com |
Initial Therapeutics is a biotechnology company discovering and developing a new class of small-molecule medicines designed to hal | South San Francisco, California | 11-50 | — |
TrueBinding Inc.truebinding.com FC  MH DS |
TrueBinding Inc. is a clinical-stage biotherapeutic company founded in 2016 that is researching and developing first-in-class mono | Foster City, California | 11-50 | — |
Cogrxcogrx.com  JI BH HC |
Cognition Therapeutics is a clinical-stage biopharmaceutical company developing zervimesine (CT1812), a once-daily oral investigat | Purchase, New York | 11-50 | — |
Acumen Pharmaceuticalsacumenpharm.com LSJB  LR |
Acumen Pharmaceuticals is a biotechnology company developing targeted therapies for Alzheimer's disease, with its most advanced ca | Boston, Massachusetts | 51-200 | — |
Leucadia Therapeuticsleucadiatx.com  NSDE |
Leucadia Therapeutics is a preclinical-stage biotechnology company developing Arethusta®, a first-in-class outpatient treatment fo | RIverside, California | 1-10 | — |
Bexion Pharmaceuticalsbexionpharma.com TA  SSKB |
Bexion Pharmaceuticals is a mid-stage clinical biopharmaceutical company developing BXQ-350, a novel S1P modulator biologic that m | Covington, Kentucky | 11-50 | — |
Amyriad Therapeuticsamyriadtherapeutics.com  ML SA |
Amyriad Therapeutics is a biotechnology research company advancing therapies for Alzheimer's Disease, with a team bringing decades | Sherwood, Oregon | 1-10 | — |
| Run live for more | ||||
Anavex Life Sciences Corp. (Nasdaq: AVXL) is a publicly traded biopharmaceutical company developing novel therapeutics for neurodegenerative and neurodevelopmental disorders including Alzheimer's disease, Parkinson's disease, Rett syndrome, schizophrenia, and other CNS diseases, as well as pain and cancer.
Companies like Anavex Life Sciences include Acadia Pharmaceuticals, Oligomerix, Initial Therapeutics, TrueBinding Inc., Cogrx. See the full list of 24 competitors and alternatives above.
Anavex Life Sciences has approximately 11-50 employees and is in the Biotechnology Research industry.
Anavex Life Sciences is headquartered in New York City, New York.
Anavex Life Sciences operates in the Biotechnology Research industry.
Key decision-makers and buying contacts at Anavex Life Sciences are listed above, including leaders across executive, finance, sales and operations.